Over the past several decades the pharmaceutical industry has developed drugs that prolong life and improve quality of life. However, there’s a dark side.
The April issue of the American Family Physician journal has an article about new national guidelines for drug treatment of asthma. You would expect that these guidelines would be unbiased and free from Big Pharma influence, but that’s not the case. In the same issue there is an editorial that speaks to this titled “Recent Changes in International Asthma Guidelines May Be Influenced by Pharmaceutical Industry Conflicts of Interest.”
